Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurent Deferred Tax LiabilityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amdocs (DOX) Liabilities and Shareholders Equity: 2009-2025

Historic Liabilities and Shareholders Equity for Amdocs (DOX) over the last 15 years, with Sep 2025 value amounting to $6.2 billion.

  • Amdocs' Liabilities and Shareholders Equity fell 2.13% to $6.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $25.1 billion, marking a year-over-year decrease of 2.25%. This contributed to the annual value of $6.2 billion for FY2025, which is 2.13% down from last year.
  • As of Q3 2025, Amdocs' Liabilities and Shareholders Equity stood at $6.2 billion, which was down 1.30% from $6.3 billion recorded in Q2 2025.
  • In the past 5 years, Amdocs' Liabilities and Shareholders Equity ranged from a high of $6.6 billion in Q1 2021 and a low of $6.2 billion during Q1 2025.
  • Its 3-year average for Liabilities and Shareholders Equity is $6.4 billion, with a median of $6.4 billion in 2024.
  • Within the past 5 years, the most significant YoY rise in Amdocs' Liabilities and Shareholders Equity was 11.79% (2021), while the steepest drop was 4.54% (2021).
  • Over the past 5 years, Amdocs' Liabilities and Shareholders Equity (Quarterly) stood at $6.6 billion in 2021, then dropped by 1.47% to $6.5 billion in 2022, then rose by 0.20% to $6.5 billion in 2023, then declined by 2.75% to $6.3 billion in 2024, then decreased by 2.13% to $6.2 billion in 2025.
  • Its Liabilities and Shareholders Equity was $6.2 billion in Q3 2025, compared to $6.3 billion in Q2 2025 and $6.2 billion in Q1 2025.